Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Endocrinologia Japonica

• Publication date

  1985-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1507/ENDOCRJ1954.32.305PMID 2995014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium.

  2009cited by this paper
• Short-term effects of 1-alpha-hydroxy-vitamin D3 in patients on corticosteroid treatment and in patients with senile osteoporosis.

  2009cited by this paper
• Immobilization osteoporosis and active vitamin D: Effect of active vitamin D analogs on the development of immobilization osteoporosis in rats

  2006cited by this paper
• 1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis.

  1982cited by this paper
• Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients.

  1981cited by this paper
• 1-34 Human parathyroid hormone radioimmunoassay: properties of antiserum against synthetic 1-34 human parathyroid hormone and its clinical application.

  1981cited by this paper
• Radioreceptor assay for 1 alpha,24(R)25-trihydroxyvitamin D3 in human serum.

  1981cited by this paper
• Treatment of spinal osteoporosis in postmenopausal women.

  1980cited by this paper
• Role of calcium regulating hormones in the pathogenesis of senile osteoporosis.

  1979cited by this paper
• Effect on bone of withdrawal of oestrogen therapy.

  1979cited by this paper
• Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.

  1979cited by this paper
• 1,25 (OH)2 Vitamin D3 in Osteoporosis - A Pilot Study* **

  1979cited by this paper
• Interim report on treatment of osteoporotic patients with 1 alpha-hydroxyvitamin D3 and calcium.

  1978cited by this paper
• Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.

  1978cited by this paper
• Biological activity of 1α,24‐dihydroxycholecalciferol; A new synthetic analog of the hormonal form of vitamin D

  1977cited by this paper
• CONTROLLED TRIAL OF 1α-HYDROXYCHOLECALCIFEROL IN CHRONIC RENAL FAILURE

  1976cited by this paper
• Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.

  1976cited by this paper
• Treatment of osteoporosis of ageing with 1alpha-hydroxycholecalciferol.

  1975cited by this paper
• Frequency of osteomalacia and osteoporosis in fractures of the proximal femur.

  1974cited by this paper
• Direct readout of bone mineral content using radionuclide absorptiometry.

  1972cited by this paper
• Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females

  1971cited by this paper
• The influence of age on the intestinal absorption of 47-Ca absorption in post-menopausal osteoporosis.

  1965cited by this paper
• ISOTOPIC TRACER STUDIES OF INTESTINAL CALCIUM ABSORPTION.

  1965cited by this paper

• A New 1,25 Dihydroxy Vitamin D Analog with Strong Bone Anabolic Activity in OVX Rats with Little or no Bone Resorptive Activity

  2020cites this paper
• Vitamin D supplementation for prevention of mortality in adults.

  2014cites this paper
• Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.

  2014cites this paper
• Vitamin D and its Metabolites and Analogs in the Management of Osteoporosis

  2013cites this paper
• Treatment of osteoporosis with vitamin D

  2010cites this paper
• Clinical Aspects of the Use of Vitamin D and Its Metabolites in Osteoporosis

  2010cites this paper
• Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.

  2009cites this paper
• Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.

  2009cites this paper
• CHAPTER 71 – Vitamin D and its Metabolites and Analogs in the Management of Osteoporosis

  2008cites this paper
• Catalytic asymmetric synthesis and anticancer effects of the novel non-calcemic analog of vitamin D, 2α-fluoro-19-nor-22-oxa-1α,25-dihydroxyvitamin D3 in metastatic lung carcinoma

  2007cites this paper
• Vitamin D and its metabolites in the pathogenesis and treatment of osteoporosis

  2006cites this paper
• CHAPTER 83 – Molecular Basis for Differential Action of Vitamin D Analogs

  2005cites this paper
• The D-hormone analog alfacalcidol: the pioneer beyond the horizon of osteoporosis treatment.

  2005cites this paper
• Treatment of osteoporosis with vitamin D3

  2005cites this paper
• Prevention of bone loss in postmenopausal and senile osteoporosis with vitamin D analogues

  2005cites this paper
• Iatrogenic Hypercalcemia Due to Vitamin D3 Ointment (1,24(OH)2D3) Combined with Thiazide Diuretics in a Case of Psoriasis

  2003cites this paper
• Vitamin D analogs as modulators of vitamin D receptor action.

  2003cites this paper
• Treatment of osteoporosis: Current status and recent advances

  2002cites this paper
• VIII: Meta-Analysis of the Efficacy of Vitamin D Treatment in Preventing Osteoporosis in Postmenopausal Women

  2002cites this paper
• Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women.

  2002cites this paper
• Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers.

  2002cites this paper
• Vitamin D and Its Metabolites in the Management of Osteoporosis

  2001cites this paper
• Effect of oral therapy with alphacalcidol or calcium in Korean elderly women with osteopenia and low dietary calcium

  2001cites this paper
• Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.

  2000cites this paper
• Vitamin D and Bone Health in Adults and the Elderly

  1999cites this paper
• Calcitonin, Bone-Active Isoflavones and Vitamin D Metabolites

  1999cites this paper
• A Double-Masked Multicenter Comparative Study Between Alendronate and Alfacalcidol in Japanese Patients with Osteoporosis

  1999cites this paper
• Treatment with Active Vitamin D Metabolites and Concurrent Treatments in the Prevention of Hip Fractures: A Retrospective Study

  1999cites this paper
• [Vitamin D and D hormones. Current status of therapy].

  1998cites this paper
• Vitamin D and its Metabolites in the Treatment of Osteoporosis

  1998cites this paper
• Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?

  1998cites this paper
• The management of osteoporosis.

  1997cites this paper
• 閉経後骨粗鬆症患者における活性型ビタミンD 1α (OH)D3長期治療の効果

  1997cites this paper
• 1 alpha-Hydroxy-vitamin D2: a new look at an 'old' compound.

  1996cites this paper
• The Vitamin D Endocrine System and Its Therapeutic Potential

  1996cites this paper
• Therapy of osteoporosis: calcium, vitamin D, and exercise.

  1996cites this paper
• Efficacy of low-dose, intermittent eel calcitonin treatment for osteoporosis

  1995cites this paper
• Treatment of osteoporosis in elderly women.

  1995cites this paper
• Treatment of osteoporosis in elderly women.

  1995cites this paper
• 12 Calcium and Vitamin D

  1994cites this paper
• Calcium and Vitamin D

  1994cites this paper
• Effects of increasing doses of 1α‐hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women

  1994cites this paper
• [Vitamin D and osteoporosis. Pathogenesis--therapy].

  1994cites this paper
• The ultra long-term treatment of senile osteoporosis with 1 alpha-hydroxyvitamin D3.

  1993cites this paper
• The ultra long-term treatment of senile osteoporosis with 1α-hydroxyvitamin D3

  1993cites this paper
• Decrease of vertebral fracture in osteoporotics by administration of 1α-hydroxy-vitamin D3

  1992cites this paper
• [The calcium and phosphorus content of the bone tissue in ovariectomized rats with a fracture of the tibia: the effect of vitamin K and vitamin D metabolites].

  1992cites this paper
• Treatment of established osteoporosis with 1α (OH) vitamin D3 and low dose intermittent elcatonin (eel calcitonin derivative)

  1992cites this paper
• Long-term treatment with 1 alpha-hydroxyvitamin D3 with calcium supplement in spinal osteoporotic patients.

  1992cites this paper
• Vitamin D in the Treatment of Osteoporosis

  1992cites this paper
• Biologic effect of 1,24(R)(OH)2D3 versus 1,25(OH)2D3 administration in chronic renal failure.

  1992cites this paper
• Relation between body size and bone mineral density with special reference to sex hormones and calcium regulating hormones in elderly females.

  1991cites this paper
• Prevention and treatment of osteopenia in the ovariectomized rat: Effect of combined therapy with estrogens, 1-alpha vitamin D, and prednisolone

  1991cites this paper
• Rational approaches to osteoporosis therapy.

  1991cites this paper
• Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.

  1990cites this paper
• The pathogenesis of osteoporosis.

  1990cites this paper
• Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis.

  1990cites this paper
• Treatment of established osteoporosis and rehabilitation: current practice and possibilities.

  1990cites this paper
• 1 alpha-hydroxylation of 24-hydroxyvitamin D2 represents a minor physiological pathway for the activation of vitamin D2 in mammals.

  1990cites this paper
• 1, 25 (OH) 2D3の老人性骨粗籟症例の骨塩含量に対する効果

  1989cites this paper
• Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3.

  1987cites this paper
• Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions.

  1986cites this paper